Amit Etkin is the founder of Alto Neuroscience. Alto Neuroscience has raised $40M in total funding. Backed by Christian Angermayer, Peter Thiel.
Amit Etkin is the founder and CEO of Alto Neuroscience, a clinical-stage biopharmaceutical company leveraging biomarkers and AI for mental health treatments. He was formerly a Professor of Psychiatry at Stanford University. Etkin's work focuses on integrating patient biology into drug development for conditions such as depression and schizophrenia.
Full founder directory · Investor directory · Company funding database · Fundraising library